Literature DB >> 22517300

Proportional hazards regression in epidemiologic follow-up studies: an intuitive consideration of primary time scale.

John Cologne1, Wan-Ling Hsu, Robert D Abbott, Waka Ohishi, Eric J Grant, Saeko Fujiwara, Harry M Cullings.   

Abstract

In epidemiologic cohort studies of chronic diseases, such as heart disease or cancer, confounding by age can bias the estimated effects of risk factors under study. With Cox proportional-hazards regression modeling in such studies, it would generally be recommended that chronological age be handled nonparametrically as the primary time scale. However, studies involving baseline measurements of biomarkers or other factors frequently use follow-up time since measurement as the primary time scale, with no explicit justification. The effects of age are adjusted for by modeling age at entry as a parametric covariate. Parametric adjustment raises the question of model adequacy, in that it assumes a known functional relationship between age and disease, whereas using age as the primary time scale does not. We illustrate this graphically and show intuitively why the parametric approach to age adjustment using follow-up time as the primary time scale provides a poor approximation to age-specific incidence. Adequate parametric adjustment for age could require extensive modeling, which is wasteful, given the simplicity of using age as the primary time scale. Furthermore, the underlying hazard with follow-up time based on arbitrary timing of study initiation may have no inherent meaning in terms of risk. Given the potential for biased risk estimates, age should be considered as the preferred time scale for proportional-hazards regression with epidemiologic follow-up data when confounding by age is a concern.

Entities:  

Mesh:

Year:  2012        PMID: 22517300     DOI: 10.1097/EDE.0b013e318253e418

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  42 in total

1.  Leukocyte Telomere Length and Cardiovascular Risk Scores for Prediction of Cardiovascular Mortality.

Authors:  Steven D Barger; Matthew R Cribbet; Matthew F Muldoon
Journal:  Epidemiology       Date:  2017-03       Impact factor: 4.822

2.  Time scale in follow-up studies: considering disease prognosis.

Authors:  Jessica Chubak; Onchee Yu; Diana S M Buist; Heidi S Wirtz; Denise M Boudreau
Journal:  Epidemiology       Date:  2013-07       Impact factor: 4.822

3.  Kidney cancer mortality and ionizing radiation among French and German uranium miners.

Authors:  Damien Drubay; Sophie Ancelet; Alain Acker; Michaela Kreuzer; Dominique Laurier; Estelle Rage
Journal:  Radiat Environ Biophys       Date:  2014-05-24       Impact factor: 1.925

4.  Measuring childhood cancer late effects: evidence of a healthy survivor effect.

Authors:  Peter Haubjerg Asdahl; Rohit Priyadarshi Ojha; Jeanette Falck Winther; Anna Sällfors Holmqvist; Sofie de Fine Licht; Thorgerdur Gudmundsdottir; Laura Madanat-Harjuoja; Laufey Tryggvadottir; Klaus Kaae Andersen; Henrik Hasle
Journal:  Eur J Epidemiol       Date:  2017-11-28       Impact factor: 8.082

5.  All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.

Authors:  Zachary S Wallace; Xiaoqing Fu; Tyler Harkness; John H Stone; Yuqing Zhang; Hyon Choi
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

6.  Long-term follow-up for incident cirrhosis among pediatric cancer survivors with hepatitis C virus infection.

Authors:  Sericea Stallings-Smith; Kevin R Krull; Tara M Brinkman; Melissa M Hudson; Rohit P Ojha
Journal:  J Clin Virol       Date:  2015-07-29       Impact factor: 3.168

7.  Survival of high-risk pediatric neuroblastoma patients in a developing country.

Authors:  Joseph C Easton; Sergio Gomez; Peter H Asdahl; J Michael Conner; Alcira B Fynn; Claudia Ruiz; Rohit P Ojha
Journal:  Pediatr Transplant       Date:  2016-05-27

8.  Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health Study.

Authors:  Fumiaki Imamura; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Alice H Lichtenstein; Nirupa R Matthan; David M Herrington; David S Siscovick; Dariush Mozaffarian
Journal:  Am J Clin Nutr       Date:  2012-10-24       Impact factor: 7.045

9.  Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability.

Authors:  Arash Delavar; Justin M Barnes; Xiaoyan Wang; Kimberly J Johnson
Journal:  JAMA Pediatr       Date:  2020-05-01       Impact factor: 16.193

10.  Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a prospective cohort study.

Authors:  Viktor Oskarsson; Nicola Orsini; Omid Sadr-Azodi; Alicja Wolk
Journal:  CMAJ       Date:  2014-01-27       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.